Michael Grusch Selected Research

Michael Grusch Research Topics

Disease

69	Neoplasms (Cancer) 01/2022 - 08/2002
12	Malignant Mesothelioma 06/2022 - 05/2011
12	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 11/2003
10	Neoplasm Metastasis (Metastasis) 10/2020 - 11/2012
10	Melanoma (Melanoma, Malignant) 01/2020 - 12/2010
9	Leukemia 01/2015 - 08/2002
7	Breast Neoplasms (Breast Cancer) 01/2017 - 12/2010
6	Adenocarcinoma of Lung 01/2021 - 01/2013
6	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 08/2004
6	Mesothelioma 08/2020 - 05/2011
6	Carcinoma (Carcinomatosis) 01/2018 - 01/2001
5	Inflammation (Inflammations) 07/2015 - 11/2006
5	Colonic Neoplasms (Colon Cancer) 11/2012 - 08/2004
4	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 09/2008
4	Ovarian Neoplasms (Ovarian Cancer) 10/2016 - 07/2009
3	Lung Neoplasms (Lung Cancer) 12/2018 - 08/2016
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2013 - 02/2008
3	Liver Neoplasms (Liver Cancer) 03/2011 - 11/2006
3	Necrosis 01/2006 - 04/2002
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2021 - 08/2016
2	Rectal Neoplasms (Rectal Cancer) 01/2019 - 10/2016
2	Nevus (Nevi) 10/2017 - 01/2015
2	Sarcoma (Soft Tissue Sarcoma) 10/2016 - 09/2015
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 08/2015 - 01/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2013 - 10/2008
2	Carcinogenesis 12/2010 - 03/2008
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2009 - 11/2006
2	Lymphoma (Lymphomas) 03/2009 - 07/2005
2	Fibrosis (Cirrhosis) 03/2008 - 11/2006

Drug/Important Bio-Agent (IBA)

13	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022 - 10/2008
11	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2003
11	DNA (Deoxyribonucleic Acid)IBA 09/2019 - 04/2002
10	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 10/2013 - 08/2002
9	Biomarkers (Surrogate Marker)IBA 10/2020 - 10/2009
8	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2015 - 08/2002
7	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022 - 01/2008
7	activin AIBA 11/2021 - 11/2006
7	ResveratrolIBA 10/2013 - 10/2006
6	Pharmaceutical PreparationsIBA 10/2020 - 03/2011
6	Biological ProductsIBA 10/2018 - 11/2003
6	EnzymesIBA 05/2015 - 08/2002
5	LigandsIBA 01/2022 - 01/2014
5	Messenger RNA (mRNA)IBA 01/2022 - 04/2012
5	Type 4 Fibroblast Growth Factor ReceptorIBA 01/2022 - 01/2014
5	Epidermal Growth Factor (EGF)IBA 01/2021 - 01/2006
5	Phosphotransferases (Kinase)IBA 01/2018 - 10/2014
5	Small Interfering RNA (siRNA)IBA 12/2015 - 01/2008
4	FollistatinIBA 11/2021 - 11/2006
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 01/2006
4	Protein Isoforms (Isoforms)IBA 01/2020 - 10/2011
4	Activins (Activin)IBA 01/2016 - 11/2003
4	ErbB Receptors (EGF Receptor)IBA 05/2015 - 10/2008
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 05/2015
3	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2020 - 12/2015
3	VemurafenibIBA 09/2019 - 01/2017
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2019 - 07/2009
3	Gallic AcidIBA 09/2019 - 01/2007
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2018 - 10/2011
3	nintedanibIBA 01/2018 - 08/2016
3	AvemarIBA 03/2009 - 02/2005
3	StilbenesIBA 06/2008 - 10/2006
2	IntegrinsIBA 01/2022 - 10/2015
2	MicroRNAs (MicroRNA)IBA 12/2019 - 01/2018
2	PD 173074IBA 12/2018 - 06/2017
2	CaspasesIBA 10/2018 - 11/2003
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2018 - 01/2017
2	AZD 6244IBA 05/2018 - 01/2017
2	Calcium-Transporting ATPases (Ca2+ ATPase)IBA 01/2017 - 01/2017
2	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 08/2016 - 09/2015
2	Anaplastic Lymphoma KinaseIBA 08/2015 - 01/2015
2	Methylene Chloride (Dichloromethane)IBA 07/2015 - 04/2009
2	Fatty Acid Synthases (Fatty Acid Synthase)IBA 05/2015 - 07/2009
2	PolyphenolsIBA 01/2015 - 10/2009
2	triphosphoric acid (triphosphate)IBA 01/2015 - 12/2010
2	Mitogen-Activated Protein KinasesIBA 10/2014 - 12/2010
2	Hormones (Hormone)IBA 03/2014 - 09/2007
2	major vault proteinIBA 11/2013 - 06/2012
2	digalloylresveratrolIBA 10/2013 - 02/2009
2	Green Fluorescent ProteinsIBA 01/2012 - 06/2010
2	Canertinib (CI 1033)IBA 09/2011 - 07/2009
2	EKB 569IBA 09/2011 - 07/2009
2	Deferoxamine (Desferal)FDA LinkGeneric 03/2011 - 01/2001
2	3,3',4,5'-tetrahydroxystilbeneIBA 12/2010 - 10/2008
2	ProteomeIBA 06/2010 - 01/2010
2	Fluorouracil (Carac)FDA LinkGeneric 02/2009 - 08/2004
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2009 - 01/2007
2	Heparin (Liquaemin)FDA LinkGeneric 12/2008 - 01/2006
2	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 12/2008 - 01/2006
2	Deuterium Oxide (Heavy Water)IBA 02/2008 - 09/2005
2	Floxuridine (FUdR)FDA LinkGeneric 07/2005 - 08/2004
2	Transferrin (beta 2 Transferrin)IBA 11/2003 - 01/2001
1	Angiogenesis InhibitorsIBA 06/2022
1	ParaffinIBA 04/2021
1	Formaldehyde (Formol)FDA Link 04/2021
1	Immune Checkpoint InhibitorsIBA 04/2021

Therapy/Procedure

24	Therapeutics 10/2020 - 02/2008
11	Drug Therapy (Chemotherapy) 01/2018 - 08/2002
4	Radiotherapy 09/2019 - 05/2011
2	Immunotherapy 04/2021 - 09/2019
2	Neoadjuvant Therapy 01/2019 - 10/2016